Naproxen Sodium Marel B.V. (Naproxen Sodium)

The drug works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin synthesis. By lowering prostaglandin levels, it reduces the signals that cause pain, swelling, and fever at the site of injury or inflammation.

The appropriate dose of Naproxen Sodium is determined by a qualified prescriber based on the patient’s condition, age, renal function, and other clinical factors. Patients should follow the prescribing information and never adjust the dose without medical guidance.

Naproxen Sodium is generally avoided in the third trimester of pregnancy because of potential risks to the fetus. Use during the first two trimesters should only be considered if the benefit outweighs the risk and under medical supervision. Limited data are available for breastfeeding, so a healthcare professional should assess safety.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Both Naproxen Sodium and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen generally has a longer half‑life, allowing less frequent dosing, while ibuprofen may have a slightly faster onset. Safety profiles are comparable, though individual patient factors may favor one over the other.

Store Naproxen Sodium at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Naproxen Sodium is administered orally, typically as a tablet or capsule that is swallowed whole with a full glass of water. It may be taken with food or milk to lessen gastrointestinal discomfort, but patients should follow the specific instructions provided by their prescriber.

Serious risks include gastrointestinal bleeding or ulceration, renal impairment, severe skin reactions such as Stevens‑Johnson syndrome, and an increased chance of cardiovascular events like heart attack or stroke, especially with long‑term or high‑dose use.

Individuals with known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal ulcers, severe renal or hepatic impairment, uncontrolled hypertension, or in the third trimester of pregnancy should avoid Naproxen Sodium. A healthcare professional should evaluate suitability for each patient.